Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress

NCT05302583 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05302583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05302583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Recruiting
Start date
June 16, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aromatherapy, cancer coping, cancer distress, hematopoetic stem cell transplant